For protocol-focused research, also see Peptide Dosing Protocols
There is growing clinical and experimental evidence demonstrating that antioxidants play a significant therapeutic role in preventing and modulating chronic diseases associated with oxidative stress, including neurodegeneration, diabetes, cardiovascular disease, and premature aging [7880]
These findings suggest that GRK2 may be a potential target for anti-angiogenic therapy
Beyond cosmetics, research has explored GHK-Cu's potential in therapeutic wound healing (chronic wounds, surgical recovery, diabetic ulcers), hair restoration, tissue engineering, nerve regeneration, lung disease, and even systemic anti-aging interventions
Applications ELISA, WB, IF, Flow Cytometry Dilutions ELISA: 1:128,000, WB: 0.1-1g/ml, IF: 10g/ml, Flow Cytometry: 10g/ml Reactivity Human, Rat, Porcine Immunogen Synthetic peptide corresponding to the internal region of human GLP-1R
Preclinical studies using in vitro-transcribed mRNA chimeric antigen receptor T cells (IVT mRNA CAR T) have shown effective, targeted cytotoxicity against various hematologic cancers, including CLL, acute lymphoblastic leukemia, and acute myeloid leukemia (AML), as well as solid tumors including mesothelioma, ovarian cancer, breast cancer, neuroblastoma, glioblastoma (GBM), and melanoma